Directed share issue in SyntheticMR AB — SEK 60 million

Carnegie acted as sole global co-ordinator and sole bookrunner in the directed share issue of 1,250,000 new shares at a subscription price of SEK 48 per share. SyntheticMR develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR has developed SyMRI, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan.
March 2022.